Danaher Corporation (NYSE:DHR) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
ITEM 5.02        DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS

On February 21, 2017, the Board of Directors of Danaher Corporation (“Danaher”) increased the size of Danaher’s Board from eleven to twelve members and appointed Raymond C. Stevens, Ph.D. to the Board to fill the newly-created vacancy, with a term expiring at Danaher’s 2017 annual meeting of shareholders. As a non-employee director, Professor Stevens will receive the same compensation paid to other non-employee directors of Danaher as disclosed in Exhibit 10.21 to Danaher’s Annual Report on Form 10-K for the year ended December 31, 2016, which is incorporated by reference herein. Professor Stevens has also entered into a director indemnification agreement with Danaher, the form of which is disclosed as Exhibit 10.30 to Danaher’s Annual Report on Form 10-K for the year ended December 31, 2016 and which is incorporated by reference herein. In connection with his appointment, the Board also determined that Professor Stevens is independent within the meaning of the listing standards of the New York Stock Exchange.

There is no arrangement or understanding between Professor Stevens and any other person to which he was selected as a director of Danaher. There are no transactions in which Professor Stevens has an interest requiring disclosure under Item 404(a) of Regulation S-K.

About Danaher Corporation (NYSE:DHR)

Danaher Corporation designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates in five segments: Test & Measurement; Environmental; Life Sciences & Diagnostics; Dental, and Industrial Technologies. Its Test & Measurement segment offers products, software and services. Its Environmental segment products and services help protect the water supply, enhance the safety of personal data and improve business efficiencies. In the Life Sciences & Diagnostics segment, its diagnostics business offers analytical instruments, reagents, consumables, software and services. Its life sciences business offers research tools. Its Dental segment provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone. Its Industrial Technologies segment solutions help protect the world’s food supply, improve packaging design and quality, and verify pharmaceutical dosages.

Danaher Corporation (NYSE:DHR) Recent Trading Information

Danaher Corporation (NYSE:DHR) closed its last trading session up +0.70 at 84.75 with 2,307,584 shares trading hands.